A recent study has revealed that dietary supplement called 'Carze' may contain a meth-like party drug.
Pieter Cohen, assistant professor of medicine at Harvard Medical School , said that they have found a drug in a mainstream sports supplement that has never been studied in humans, CBS News reported.
Cohen added that the health risk of using supplements adulterated with a drug should not be underestimated.
Researchers have looked into the Craze supplement, which is marketed by Driven Sports, Inc., after it was flagged in several failed drug tests.
Cohen teamed up with the independent testing global health organization NSF International to analyze the supplement's contents.
Their study found that a substance called N,alpha-diethylphenylethylamine (N,a-DEPEA) which has been termed structurally similar to methamphetamine by scientists, was present in the supplement.
According to the analysis, the stimulant is less potent than methamphetamine, but more potent than stimulant called 'ephedra,' which has been banned by the Food and Drug Administration after been linked to heart attacks.
The researchers have also found the meth-like compound in a weight loss supplement called Detonate, which is marketed by Gaspari Nutrition.
The study has been published in the Drug Testing and Analysis journal.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
